- Gap Filling Done
- Trendline tested 4 times i.e. weakening
- Two Dojis at the gap zone indicating indecision
- A good bullish sign here can mean a potential up move
- Given that the pharma sector hasn't performed in the last year, we may see some momentum in the coming period.
DISCLAIMER: We are not registered. We are not advisors. Everything here is merely for educational purposes and is a purely personal opinion. Please consult your advisor before investing.
- Trendline tested 4 times i.e. weakening
- Two Dojis at the gap zone indicating indecision
- A good bullish sign here can mean a potential up move
- Given that the pharma sector hasn't performed in the last year, we may see some momentum in the coming period.
DISCLAIMER: We are not registered. We are not advisors. Everything here is merely for educational purposes and is a purely personal opinion. Please consult your advisor before investing.
Note
12% in already. Booked part profits.Now we await the trendline breakout. We may hit the Moon.
Note
25% IN !! 🚀🚀🚀🚀Note
Another 5% Booster. We have now reached a resistance zone.Note
Divis is Consolidating at the resistance zone. The Psy. Level of 4000 can be a major hurdle🎯 You can now access our personal charts for all Nifty 500 companies📈
👉 Visit nas.io/TradeWithTc to learn Price Action with real life case studies.
#BeYourOwnAnalyst
👉 Visit nas.io/TradeWithTc to learn Price Action with real life case studies.
#BeYourOwnAnalyst
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
🎯 You can now access our personal charts for all Nifty 500 companies📈
👉 Visit nas.io/TradeWithTc to learn Price Action with real life case studies.
#BeYourOwnAnalyst
👉 Visit nas.io/TradeWithTc to learn Price Action with real life case studies.
#BeYourOwnAnalyst
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.